Rakesh Jain, MD

  • 31Articles
  • 152.6KReads
  • 2004–2024Active
  • 53Collaborators
  • 474Citations

About

Rakesh Jain, MD is affiliated with Department of Psychiatry, Texas Tech University School of Medicine-Permian Basin, Midland, Texas. Rakesh Jain has authored or co-authored 31 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2004 and 2024. Their work focuses on Depression (MDD), Bipolar Disorder, Neurology, Primary Care, and Somatoform Disorders.

Publications

JCP
Dysregulation of Noradrenergic Activity
Academic Highlights

Dysregulation of Noradrenergic Activity

November 8, 2024

Dysregulation of noradrenergic activity plays a key role in symptom presentation in major depressive disorder, schizophrenia, Alzheimer’s agitation, and PTSD. This article provides an expert panel’s consensus regarding the...
, , , et al
JCP
Impact of Tardive Dyskinesia on Patient Lives
Original Research

Impact of Tardive Dyskinesia on Patient Lives

April 3, 2023

This survey reveals the substantial burden of tardive dyskinesia on people’s lives and on the management of their underlying condition.
, , , et al
PCC
Original Research

Efficacy of Cariprazine in Bipolar Disorder

September 17, 2020

Bipolar disorder is characterized by a chronic and subtle course of fluctuating symptoms. To explore the efficacy of cariprazine across the symptoms of bipolar depression, post hoc analyses of...
, , , et al
JCP
Consensus Statement

Screening, Diagnosis, and Treatment of Tardive Dyskinesia

January 28, 2020

Tardive dyskinesia remains a serious complication associated with dopamine receptor blocking agents. In this article, read guidance from experts on best practices for tardive dyskinesia screening, diagnosis, and treatment.
, , , et al
JCP
Academic Highlights

What is Tardive Dyskinesia?

March 20, 2018

Read a study where experts review the prevalence, phenomenology, risk factors, and impact of Tardive Dyskinesia (TD).
,
JCP
Educational Activity

Remission Strategies for MDD

January 9, 2018

Most patients with major depressive disorder will not achieve remission with initial treatment. Strategies to increase the likelihood of achieving remission include regularly measuring response, assessing adverse effects and...
JCP
Academic Highlights

Depression With Mixed Features

September 26, 2017

Descriptions of mixed states can be found in the writings of ancient Greek physicians, and the concept continues to be refined. In this CME activity, join experts as they...
, ,
PCC
Article

Diagnosis and Treatment of Adult ADHD

September 7, 2017

ADHD was originally defined in children but is now recognized to persist into adulthood for some patients. Despite this recognition, adult ADHD remains underdiagnosed. This article describes the negative...
, ,
PCC
Article

Medications for ADHD

August 18, 2016

With more than 20 different pharmacologic options for the treatment of ADHD, how do you know what will work best for your patients? Read this systematic review to find...
,
JCP
Educational Activity

Resolving Residual Symptoms in Primary Care Patients With Depression

February 24, 2016

, ,
JCP
Educational Activity

The Identification and Resolution of Residual Symptoms in Depressed Primary Care Patients

January 27, 2016

JCP
Educational Activity

Improving Adherence in Primary Care Patients With Depression

December 23, 2015

, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe